La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys

Identifieur interne : 004454 ( Main/Exploration ); précédent : 004453; suivant : 004455

Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys

Auteurs : P. Blanchet [Canada] ; P. J. Bedard [Canada] ; D. R. Britton ; J. W. Kebabian

Source :

RBID : Pascal:94-0039779

Descripteurs français

English descriptors

Abstract

The motor effects of selective D-1 dopamine receptor stimulation in Parkinson's disease have been explored in a limited number of studies with partial D-1 agonists only and the results were unsatisfactory


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys</title>
<author>
<name sortKey="Blanchet, P" sort="Blanchet, P" uniqKey="Blanchet P" first="P." last="Blanchet">P. Blanchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hôp. Enfant-Jésus, cent. rech. neurobiologie</s1>
<s2>Québec PQ G1J 1Z4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec PQ G1J 1Z4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hôp. Enfant-Jésus, cent. rech. neurobiologie</s1>
<s2>Québec PQ G1J 1Z4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec PQ G1J 1Z4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Britton, D R" sort="Britton, D R" uniqKey="Britton D" first="D. R." last="Britton">D. R. Britton</name>
</author>
<author>
<name sortKey="Kebabian, J W" sort="Kebabian, J W" uniqKey="Kebabian J" first="J. W." last="Kebabian">J. W. Kebabian</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">94-0039779</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 94-0039779 INIST</idno>
<idno type="RBID">Pascal:94-0039779</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001037</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000E88</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000F45</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000F45</idno>
<idno type="wicri:doubleKey">0022-3565:1993:Blanchet P:differential:effect:of</idno>
<idno type="wicri:Area/Main/Merge">004C61</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7901395</idno>
<idno type="wicri:Area/PubMed/Corpus">001A00</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A00</idno>
<idno type="wicri:Area/PubMed/Curation">001A00</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A00</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A00</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A00</idno>
<idno type="wicri:Area/Ncbi/Merge">002425</idno>
<idno type="wicri:Area/Ncbi/Curation">002425</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002425</idno>
<idno type="wicri:doubleKey">0022-3565:1993:Blanchet P:differential:effect:of</idno>
<idno type="wicri:Area/Main/Merge">004B11</idno>
<idno type="wicri:Area/Main/Curation">004454</idno>
<idno type="wicri:Area/Main/Exploration">004454</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys</title>
<author>
<name sortKey="Blanchet, P" sort="Blanchet, P" uniqKey="Blanchet P" first="P." last="Blanchet">P. Blanchet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hôp. Enfant-Jésus, cent. rech. neurobiologie</s1>
<s2>Québec PQ G1J 1Z4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec PQ G1J 1Z4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Hôp. Enfant-Jésus, cent. rech. neurobiologie</s1>
<s2>Québec PQ G1J 1Z4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec PQ G1J 1Z4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Britton, D R" sort="Britton, D R" uniqKey="Britton D" first="D. R." last="Britton">D. R. Britton</name>
</author>
<author>
<name sortKey="Kebabian, J W" sort="Kebabian, J W" uniqKey="Kebabian J" first="J. W." last="Kebabian">J. W. Kebabian</name>
</author>
</analytic>
<series>
<title level="j" type="main">(The) Journal of pharmacology and experimental therapeutics</title>
<title level="j" type="abbreviated">J. pharmacol. exp. ther.</title>
<idno type="ISSN">0022-3565</idno>
<imprint>
<date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">(The) Journal of pharmacology and experimental therapeutics</title>
<title level="j" type="abbreviated">J. pharmacol. exp. ther.</title>
<idno type="ISSN">0022-3565</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>Animals</term>
<term>Antiparkinson agent</term>
<term>D1 Dopamine receptor</term>
<term>D2 Dopamine receptor</term>
<term>Dopamine (physiology)</term>
<term>Dopamine Agents (pharmacology)</term>
<term>Dopamine agonist</term>
<term>Dyskinesia</term>
<term>Dyskinesia, Drug-Induced (physiopathology)</term>
<term>Female</term>
<term>Levodopa</term>
<term>Levodopa (toxicity)</term>
<term>MPTP Poisoning</term>
<term>Macaca fascicularis</term>
<term>Mechanism of action</term>
<term>Monkey</term>
<term>Motor Activity (drug effects)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Receptors, Dopamine D1 (drug effects)</term>
<term>Receptors, Dopamine D2 (drug effects)</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en">
<term>Receptors, Dopamine D1</term>
<term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Dopamine Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Motor Activity</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en">
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Female</term>
<term>MPTP Poisoning</term>
<term>Macaca fascicularis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Lévodopa</term>
<term>Antiparkinsonien</term>
<term>Toxicité</term>
<term>Dyskinésie</term>
<term>Singe</term>
<term>Animal</term>
<term>Récepteur dopaminergique D1</term>
<term>Récepteur dopaminergique D2</term>
<term>Stimulant dopaminergique</term>
<term>Mécanisme action</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Singe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The motor effects of selective D-1 dopamine receptor stimulation in Parkinson's disease have been explored in a limited number of studies with partial D-1 agonists only and the results were unsatisfactory</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Britton, D R" sort="Britton, D R" uniqKey="Britton D" first="D. R." last="Britton">D. R. Britton</name>
<name sortKey="Kebabian, J W" sort="Kebabian, J W" uniqKey="Kebabian J" first="J. W." last="Kebabian">J. W. Kebabian</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Blanchet, P" sort="Blanchet, P" uniqKey="Blanchet P" first="P." last="Blanchet">P. Blanchet</name>
</noRegion>
<name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004454 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004454 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:94-0039779
   |texte=   Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022